CAAS Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$218K Sell
3,000
-5,100
-63% -$402K 0.02% 357
2024
Q4
$585K Buy
8,100
+4,100
+103% +$311K 0.1% 150
2024
Q3
$326K Buy
+4,000
New +$348K 0.04% 270
2024
Q2
Sell
-86,000
Closed -$8.36M 393
2024
Q1
$8.36M Sell
86,000
-57,000
-40% -$5.01M 0.61% 46
2023
Q4
$11.2M Buy
143,000
+41,000
+40% +$2.79M 1.18% 23
2023
Q3
$6.39M Buy
102,000
+17,000
+20% +$1.12M 0.42% 63
2023
Q2
$5.46M Buy
85,000
+6,000
+8% +$338K 0.36% 79
2023
Q1
$4.19M Sell
79,000
-78,000
-50% -$3.83M 0.22% 109
2022
Q4
$6.6M Sell
157,000
-124,000
-44% -$5.19M 0.4% 81
2022
Q3
$10.3M Buy
281,000
+84,000
+43% +$3.74M 0.49% 35
2022
Q2
$8.39M Buy
+197,000
New +$9.38M 0.42% 56
2022
Q1
Sell
-51,000
Closed -$3.67M 820
2021
Q4
$3.67M Sell
51,000
-93,000
-65% -$5.83M 0.09% 225
2021
Q3
$8.2M Buy
+144,000
New +$8.76M 0.16% 132
2020
Q3
Sell
-100,000
Closed -$3.23M 553
2020
Q2
$3.23M Buy
100,000
+48,000
+92% +$1.31M 0.11% 173
2020
Q1
$1.25M Buy
+52,000
New +$1.5M 0.13% 123

Other funds holding LRCX

CAAS Capital Management's LRCX Position: Q4 2023 in Review

CAAS Capital Management sold out of Lam Research (LRCX) in Q4 2023, closing a stake of 51,000 shares — an estimated $3.48M sold.

CAAS Capital Management first reported a position in LRCX in Q1 2020 and held it in 7 quarters. The position peaked at $5.53M in Q3 2022. 1,630 funds tracked by Wall St. Rank hold LRCX as of Q4 2023.

  • CAAS Capital Management reported no remaining Lam Research position as of Q4 2023 after selling out during the quarter.
  • CAAS Capital Management sold 51,000 Lam Research shares in Q4 2023, an estimated $3.48M.
  • CAAS Capital Management first reported a position in Lam Research in Q1 2020 and held it in 7 quarters.
  • CAAS Capital Management's Lam Research position peaked at $5.53M in Q3 2022.
  • 1,630 funds tracked by Wall St. Rank held Lam Research as of Q4 2023.

Based on CAAS Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.